Cellectis S.A.

ENXTPA:ALCLS Stock Report

Market Cap: €96.3m

Cellectis Future Growth

Future criteria checks 1/6

Cellectis's earnings are forecast to decline at 17.3% per annum while its annual revenue is expected to grow at 14.8% per year. EPS is expected to decline by 39.1% per annum.

Key information

-17.3%

Earnings growth rate

-39.09%

EPS growth rate

Biotechs earnings growth60.7%
Revenue growth rate14.8%
Future return on equityn/a
Analyst coverage

Low

Last updated15 Sep 2026

Recent future growth updates

Analysis Article • Aug 09

Cellectis S.A. (EPA:ALCLS) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholders might have noticed that Cellectis S.A. ( EPA:ALCLS ) filed its quarterly result this time last week. The...
Analysis Article • May 14

Cellectis S.A. (EPA:ALCLS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

It's been a good week for Cellectis S.A. ( EPA:ALCLS ) shareholders, because the company has just released its latest...

Recent updates

Analysis Article • Aug 09

Cellectis S.A. (EPA:ALCLS) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholders might have noticed that Cellectis S.A. ( EPA:ALCLS ) filed its quarterly result this time last week. The...
Analysis Article • May 14

Cellectis S.A. (EPA:ALCLS) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

It's been a good week for Cellectis S.A. ( EPA:ALCLS ) shareholders, because the company has just released its latest...
Analysis Article • Nov 08

Lacklustre Performance Is Driving Cellectis S.A.'s (EPA:ALCLS) 26% Price Drop

The Cellectis S.A. ( EPA:ALCLS ) share price has softened a substantial 26% over the previous 30 days, handing back...
Analysis Article • Sep 23

Subdued Growth No Barrier To Cellectis S.A. (EPA:ALCLS) With Shares Advancing 26%

Cellectis S.A. ( EPA:ALCLS ) shares have continued their recent momentum with a 26% gain in the last month alone. The...
Analysis Article • Jul 15

Cellectis S.A. (EPA:ALCLS) Stock Catapults 30% Though Its Price And Business Still Lag The Industry

Cellectis S.A. ( EPA:ALCLS ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
Analysis Article • Jun 20

It's Unlikely That Cellectis S.A.'s (EPA:ALCLS) CEO Will See A Huge Pay Rise This Year

Key Insights Cellectis' Annual General Meeting to take place on 26th of June Total pay for CEO Andre Choulika includes...
Analysis Article • May 17

Need To Know: The Consensus Just Cut Its Cellectis S.A. (EPA:ALCLS) Estimates For 2025

Market forces rained on the parade of Cellectis S.A. ( EPA:ALCLS ) shareholders today, when the analysts downgraded...
Analysis Article • May 04

Improved Revenues Required Before Cellectis S.A. (EPA:ALCLS) Stock's 32% Jump Looks Justified

Those holding Cellectis S.A. ( EPA:ALCLS ) shares would be relieved that the share price has rebounded 32% in the last...
Analysis Article • Jan 01

Is Cellectis (EPA:ALCLS) Using Debt In A Risky Way?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 07

A Look At The Intrinsic Value Of Cellectis S.A. (EPA:ALCLS)

Does the February share price for Cellectis S.A. ( EPA:ALCLS ) reflect what it's really worth? Today, we will estimate...
Analysis Article • Aug 09

Analyst Forecasts Just Became More Bearish On Cellectis S.A. (EPA:ALCLS)

One thing we could say about the analysts on Cellectis S.A. ( EPA:ALCLS ) - they aren't optimistic, having just made a...
Analysis Article • Dec 14

Is Cellectis (EPA:ALCLS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Aug 07

Analysts' Revenue Estimates For Cellectis S.A. (EPA:ALCLS) Are Surging Higher

Cellectis S.A. ( EPA:ALCLS ) shareholders will have a reason to smile today, with the analysts making substantial...

Earnings and Revenue Growth Forecasts

ENXTPA:ALCLS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202859-176-107-1413
12/31/202775-109-85-1145
12/31/202655-85-24-525
6/30/202664-65-45-42N/A
3/31/202675-67-41-38N/A
12/31/202580-68-43-39N/A
9/30/202583-35-34-29N/A
6/30/202563-59-37-33N/A
3/31/202555-612529N/A
12/31/202449-371923N/A
9/30/202436-846063N/A
6/30/202420-795151N/A
3/31/202412-78-21-20N/A
12/31/20239-109-26-25N/A
9/30/202325-92-67-66N/A
6/30/202325-97-78-75N/A
3/31/202325-91-81-79N/A
12/31/202226-91-90-87N/A
9/30/2022-5-63-109-107N/A
6/30/20224-78-118-112N/A
3/31/202214-99-111-100N/A
12/31/202139-86-123-105N/A
9/30/202168-129-154-117N/A
6/30/202167-121-151-113N/A
3/31/202159-113-169-123N/A
12/31/202060-37-125-80N/A
9/30/202073-79-80-49N/A
6/30/202073-66-76-46N/A
3/31/202071-67N/A-45N/A
12/31/201923-102N/A-69N/A
9/30/201920-88N/A-87N/A
6/30/201911-95N/A-79N/A
3/31/201917-69N/A-71N/A
12/31/201821-79N/A-68N/A
9/30/201825-83N/A-57N/A
6/30/201831-86N/A-58N/A
3/31/201831-105N/A-56N/A
12/31/201734-99N/A-52N/A
9/30/201740-86N/A-41N/A
6/30/201745-74N/AN/AN/A
3/31/201757-56N/A-28N/A
12/31/201656-67N/A-33N/A
9/30/201676-45N/A-6N/A
6/30/201674-45N/AN/AN/A
3/31/201665-64N/A-17N/A
12/31/201563-23N/A4N/A
9/30/201539-28N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALCLS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ALCLS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ALCLS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ALCLS's revenue (14.8% per year) is forecast to grow faster than the French market (5.8% per year).

High Growth Revenue: ALCLS's revenue (14.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ALCLS's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/21 03:45
End of Day Share Price 2026/09/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cellectis S.A. is covered by 21 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Jack AllenBaird
Lukas ShumwayBarclays